BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21669419)

  • 1. Antifungal efficacy of propolis against fluconazole-resistant Candida glabrata isolates obtained from women with recurrent vulvovaginal candidiasis.
    Shokri H; Khosravi AR; Yalfani R
    Int J Gynaecol Obstet; 2011 Aug; 114(2):158-9. PubMed ID: 21669419
    [No Abstract]   [Full Text] [Related]  

  • 2. Biofilms Formed by Isolates from Recurrent Vulvovaginal Candidiasis Patients Are Heterogeneous and Insensitive to Fluconazole.
    Sherry L; Kean R; McKloud E; O'Donnell LE; Metcalfe R; Jones BL; Ramage G
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India.
    Lattif AA; Mukhopadhyay G; Banerjee U; Goswami R; Prasad R
    J Microbiol Immunol Infect; 2011 Jun; 44(3):166-71. PubMed ID: 21524609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics and Antifungal Susceptibility of Candida nivariensis from Vulvovaginal Candidiasis.
    Shi Y; Zhu Y; Fan S; Vitagliano A; Liu X; Liao Y; Liang Y; Vitale SG
    Gynecol Obstet Invest; 2020; 85(1):88-93. PubMed ID: 31694024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of voriconazole treatment in chronic vulvovaginal candidosis due to Candida glabrata].
    Gomez-Moyano E; Cid Lama A; Fernández Ballesteros MD; Lova Navarro M; Vera Casaño A; Crespo Erchiga V
    Rev Iberoam Micol; 2013 Jan; 30(1):61-3. PubMed ID: 22885618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulvovaginal candidiasis in a Flemish patient population.
    De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
    Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Identification and susceptibility against fluconazole and albaconazole of 100 yeasts' strains isolated from vaginal discharge].
    Arechavala AI; Bianchi MH; Robles AM; Santiso G; Negroni R
    Rev Iberoam Micol; 2007 Dec; 24(4):305-8. PubMed ID: 18095765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment.
    de Freitas ALD; Kaplum V; Rossi DCP; da Silva LBR; Melhem MSC; Taborda CP; de Mello JCP; Nakamura CV; Ishida K
    J Ethnopharmacol; 2018 Apr; 216():184-190. PubMed ID: 29325916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Inhibitory Effect of Human Beta-defensin-3 on
    Inthanachai T; Thammahong A; Edwards SW; Virakul S; Kiatsurayanon C; Chiewchengchol D
    Immunol Invest; 2021 Jan; 50(1):80-91. PubMed ID: 32316784
    [No Abstract]   [Full Text] [Related]  

  • 10. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.
    Goswami D; Goswami R; Banerjee U; Dadhwal V; Miglani S; Lattif AA; Kochupillai N
    J Infect; 2006 Feb; 52(2):111-7. PubMed ID: 15908007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy.
    Shahid Z; Sobel JD
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):354-6. PubMed ID: 19501794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata.
    Oliveira ER; Fothergill AW; Kirkpatrick WR; Coco BJ; Patterson TF; Redding SW
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3544-5. PubMed ID: 16048980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo activity of Sapindus saponaria against azole-susceptible and -resistant human vaginal Candida species.
    Damke E; Tsuzuki JK; Cortez DA; Ferreira IC; Bertoni TA; Batista MR; Donati L; Svidzinski TI; Consolaro ME
    BMC Complement Altern Med; 2011 May; 11():35. PubMed ID: 21542936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil.
    Boatto HF; Cavalcanti SD; Del Negro GM; Girão MJ; Francisco EC; Ishida K; Gompertz OF
    Mem Inst Oswaldo Cruz; 2016 Jun; 111(6):407-10. PubMed ID: 27304096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.
    Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Barton R; Bijie H; Bille J; Chang SC; da Luz Martins M; Duse A; Dzierzanowska D; Ellis D; Finquelievich J; Gould I; Gur D; Hoosen A; Lee K; Mallatova N; Mallie M; Peng NG; Petrikos G; Santiago A; Trupl J; VanDen Abeele AM; Wadula J; Zaidi M;
    Diagn Microbiol Infect Dis; 2010 Jun; 67(2):162-71. PubMed ID: 20338711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of recurrent vulvovaginal candidosis with mycosyst (fluconazole)].
    Pekhlivanov B; Amaliev I; Ivancheva Kh; Zisova L
    Akush Ginekol (Sofiia); 2005; 44 Suppl 2():25-7. PubMed ID: 16028400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
    Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.
    Sobel JD; Wiesenfeld HC; Martens M; Danna P; Hooton TM; Rompalo A; Sperling M; Livengood C; Horowitz B; Von Thron J; Edwards L; Panzer H; Chu TC
    N Engl J Med; 2004 Aug; 351(9):876-83. PubMed ID: 15329425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of Candida glabrata in vulvovaginal candidiasis should be attributed to selective pressure or virulence ability?
    Nakamura-Vasconcelos SS; Fiorini A; Zanni PD; Bonfim-Mendonça PS; Godoy JR; Almeida-Apolonio AA; Consolaro MEL; Svidzinski TIE
    Arch Gynecol Obstet; 2017 Sep; 296(3):519-526. PubMed ID: 28730269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MALDI-TOF typing highlights geographical and fluconazole resistance clusters in Candida glabrata.
    Dhieb C; Normand AC; Al-Yasiri M; Chaker E; El Euch D; Vranckx K; Hendrickx M; Sadfi N; Piarroux R; Ranque S
    Med Mycol; 2015 Jun; 53(5):462-9. PubMed ID: 25841053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.